129 Multicentre real-world HER2 (ERBB2)-positive lung adenocarcinoma across two UK tertiary centres: testing rates and clinicopathological characterisation
Fields of Study & Subjects
Lung Cancer Treatments and Mutations
HER2/EGFR in Cancer Research
Cancer Genomics and Diagnostics
Publication details
- Journal / source
- Lung Cancer
- Volume
- 212
- Pages
- 109078–109078
- Publication date
- 1 February 2026
- Language
- EN